Rare Disease Medical Partner, HNT

ABOUT ASTRAZENECA

Astra Zeneca is a global, science-led, patient-focused biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines for some of the world’s most serious diseases. But we’re more than one of the world’s leading pharmaceutical companies.

ROLE SUMMARY

Astra Zeneca is accelerating the expansion of our geographical footprint in rare diseases following the acquisition of Alexion in 2021. Rare diseases is a high-growth therapy area with rapid innovation and significant ...